After Sputnik V, Russia To Register Another Vaccine Against Covid-19 By 15 October

After the launch of its first vaccine against Covid-19 Sputnik V, Russia is planning to register another potential vaccine candidate by 15 October, Reuters reported citing Russian news agency TASS.

Citing Russian consumer safety watchdog Rospotrebnadzor, the report said, the vaccine had been developed by Siberia's Vector Institute. The Institute has already finished early-stage human trials of the candidate last week, the report added.

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund.

Sputnik V Gam-COVID-Vac Lyo is based on the DNA of a SARS-CoV-2 type adenovirus, a common cold virus. The vaccine uses the weakened virus to deliver small parts of a pathogen and stimulate an immune response.